- Home
- CTXR vs BSLK Comparison
CTXR vs BSLK Comparison
Compare CTXR & BSLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- BSLK
- Stock Information
- Founded
- CTXR 2007
- BSLK 2009
- Country
- CTXR United States
- BSLK United States
- Employees
- CTXR N/A
- BSLK N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- BSLK
- Sector
- CTXR Health Care
- BSLK
- Exchange
- CTXR Nasdaq
- BSLK NYSE
- Market Cap
- CTXR 14.6M
- BSLK 12.3M
- IPO Year
- CTXR N/A
- BSLK N/A
- Fundamental
- Price
- CTXR $0.94
- BSLK $6.10
- Analyst Decision
- CTXR Strong Buy
- BSLK
- Analyst Count
- CTXR 2
- BSLK 0
- Target Price
- CTXR $54.50
- BSLK N/A
- AVG Volume (30 Days)
- CTXR 142.3K
- BSLK 66.7K
- Earning Date
- CTXR 05-23-2025
- BSLK 05-12-2025
- Dividend Yield
- CTXR N/A
- BSLK N/A
- EPS Growth
- CTXR N/A
- BSLK N/A
- EPS
- CTXR N/A
- BSLK N/A
- Revenue
- CTXR N/A
- BSLK $1,525,000.00
- Revenue This Year
- CTXR N/A
- BSLK N/A
- Revenue Next Year
- CTXR N/A
- BSLK N/A
- P/E Ratio
- CTXR N/A
- BSLK N/A
- Revenue Growth
- CTXR N/A
- BSLK N/A
- 52 Week Low
- CTXR $0.68
- BSLK $4.54
- 52 Week High
- CTXR $26.25
- BSLK $340.40
- Technical
- Relative Strength Index (RSI)
- CTXR 51.36
- BSLK N/A
- Support Level
- CTXR $0.65
- BSLK N/A
- Resistance Level
- CTXR $0.82
- BSLK N/A
- Average True Range (ATR)
- CTXR 0.09
- BSLK 0.00
- MACD
- CTXR 0.04
- BSLK 0.00
- Stochastic Oscillator
- CTXR 85.69
- BSLK 0.00
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About BSLK BOLT PROJECTS HOLDINGS INC
Bolt Projects Holdings Inc develops and produces biomaterials products. Its flagship products from its Vegan Silk Technology Platform, b-silk and xl-silk, are a biodegradable and vegan protein polymer and a replacement for silicone elastomers in beauty and personal care.